Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (2024-25)
Product name
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
Sponsor name
Eli Lilly Australia Pty Ltd
Year Range
2024-25